© Gilles Galoyer
Health area
EVENT
VETERINARY MEDICINE
30 years of innovation and progress:
what are the prospects?
In a space located in the heart of the show, Gallery 6, the Health Center invites all those who gravitate in the world of horses? riders,breeders and all horse lovers to learn about the most common pathologies and the well-being of the animal. Equine health professionals offer an interactive, educational and fun tour, conferences, demonstrations to guide visitors in their quest for a better knowledge of horse health. A representative of human sports medicine also provides information on the health of the rider.
Created in 2007, at the initiative of Equita Lyon, the Lyon Horse Show, and several partners, including Boehringer Ingelheim, the second largest global player in the animal health sector and number 1 in horse health, the Equine Center of the Lyon Veterinary Campus (VetAgro Sup), the Champ du Perier equine clinic and a representative of human sports medicine, the Health Center aims to inform all audiences who gravitate around horses about the most common pathologies.
EQUIRENCONTRES 2025
Friday 31st October from 2pm to 4pm
Pôle Santé conference room
Organised by Boehringer Ingelheim and presented by leading veterinarians, the Equirencontres will be held on Friday 31 October from 2.00 pm to 4.00 pm in the conference area of the Health Pole at Equita Lyon. The aim of these Equirencontres is to make the subjects covered concerning the horse's health and well-being accessible to all.
Theme 2025 :
The sector facing the climate:
rethinking horse riding in the era of global warming
With the participation of :
Anne-Lise Pepin (IFCE engineer)
Charlotte Fustec (director of the EquuRES label)
Dr Nicolas Herteman (Boehringer Ingelheim)
Round table moderated by: Mathilde LABAT, amateur rider/owner,
influencer in the ‘Mathilde & Sligo’ equestrian community.
PROGRAMME AVAILABLE SOON
(Free access with admission to Equita Lyon)
*Programme & speakers subject to change
BOEHRINGER INGELHEIM: NO.1 WORLDWIDE IN ANIMAL HEALTH
Boehringer Ingelheim develops innovative treatments for human and animal health. As a research-driven biopharmaceutical company, Boehringer Ingelheim creates value through innovation in areas where essential medical needs exist, which have not been met. Boehringer Ingelheim has been a family-owned company since it was founded in 1885, and is built on a long-term vision. Nearly 52,000 employees in more than 130 countries work in three activities: human health, animal health and biopharmaceutical manufacturing for third parties.
The second biggest company in the world in the animal health sector and the leading one for horse health.
With 9,700 employees worldwide, including 2,100 in France, Boehringer Ingelheim’s Animal Health Division supplies vaccines and drugs to over 150 markets, to improve animals’ health and well-being.
Boehringer Ingelheim's goal is to promote, prevent and raise awareness of equine health issues among all stakeholders, and it is committed to forging unique links with each player in the equine industry. Boehringer Ingelheim has been a partner of the French Equestrian Federation (FFE) since 2008, and since 2019, it has strengthened its link with this prestigious stakeholder in the equine world and now supports France in all competitions.